- Home
- MGTX vs REAL Comparison
MGTX vs REAL Comparison
Compare MGTX & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- REAL
- Stock Information
- Founded
- MGTX 2015
- REAL 2011
- Country
- MGTX United States
- REAL United States
- Employees
- MGTX N/A
- REAL N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- REAL Other Specialty Stores
- Sector
- MGTX Health Care
- REAL Consumer Discretionary
- Exchange
- MGTX Nasdaq
- REAL Nasdaq
- Market Cap
- MGTX 622.0M
- REAL 639.0M
- IPO Year
- MGTX N/A
- REAL 2019
- Fundamental
- Price
- MGTX $7.65
- REAL $5.24
- Analyst Decision
- MGTX Strong Buy
- REAL Buy
- Analyst Count
- MGTX 2
- REAL 6
- Target Price
- MGTX $24.00
- REAL $8.33
- AVG Volume (30 Days)
- MGTX 691.3K
- REAL 2.5M
- Earning Date
- MGTX 08-11-2025
- REAL 08-07-2025
- Dividend Yield
- MGTX N/A
- REAL N/A
- EPS Growth
- MGTX N/A
- REAL N/A
- EPS
- MGTX N/A
- REAL N/A
- Revenue
- MGTX $34,508,000.00
- REAL $616,717,000.00
- Revenue This Year
- MGTX $228.65
- REAL $11.73
- Revenue Next Year
- MGTX $145.06
- REAL $9.98
- P/E Ratio
- MGTX N/A
- REAL N/A
- Revenue Growth
- MGTX 203.23
- REAL 11.89
- 52 Week Low
- MGTX $3.85
- REAL $2.24
- 52 Week High
- MGTX $8.98
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- MGTX 46.02
- REAL 43.70
- Support Level
- MGTX $8.32
- REAL $5.17
- Resistance Level
- MGTX $8.31
- REAL $6.69
- Average True Range (ATR)
- MGTX 0.39
- REAL 0.34
- MACD
- MGTX -0.19
- REAL -0.07
- Stochastic Oscillator
- MGTX 13.36
- REAL 14.20
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.